Efficiency and Safety of High-frequency Radio Wave Electrotherapy With a Radio Frequency of 448 kHz in the Treatment of Patients With Organic Erectile Dysfunction.

Inclusion Criteria:

1. Patients aged 18 to 79 years;
2. The diagnosis is confirmed by assessing the functional criteria of arterial factors ofpanel hemodynamics (dopplerography);
3. The diagnosis is confirmed by the assessment of the IIEF-5 questionnaire
4. Patients with organic erectile dysfunction lasting at least 6 months.
5. Patients with IIEF from 6 to 22 points.
6. Patients with a permanent sexual partner for more than 3 months;
7. Sexually Active Patients. Non-inclusion criteria:
8. The use of other treatments for erectile dysfunction
9. Age under 18 and over 79 years old;
10. Anatomical deformation of the penis (angulation, cavernous fibrosis or Peyronie'sdisease);
11. The presence of diseases predisposing to the development of priapism (sickle cellanemia, multiple myeloma, leukemia, thrombocytopenia);
12. Running coagulation disorders;
13. The presence of tumors in the area of electrotherapy;
14. The presence of aneurysms in the propagation of radio frequency waves;
15. Angina pectoris;
16. Myocardial infarction, stroke, life-threatening arrhythmias;
17. Thrombosis, thromboembolic disease;
18. Arterial hypertension (blood pressure ≥ 170/90 mm Hg) or hypotension (blood pressure ≤ 90/50 mm Hg.);
19. The patient has a mental illness that does not allow an assessment of theeffectiveness of therapy; history of alcoholism and drug addiction;
20. Active tuberculosis, chronic somatic diseases in the acute stage; 15. Condition aftercoronary artery bypass grafting (CABG); 16. Patient's involvement in another clinical trialin the last 3 months;

Exclusion Criteria:

1. Serious unwanted phenomenons associated with exposure to the apparatus.
2. Incorrect inclusion in the study.
3. A marked deterioration in the patient's condition due to an increase in the severityof the disease or the attachment of another disease.
4. The patient's appearance of non-inclusion criteria during the study.
5. Serious deviation from the protocol.
6. The desire of the patient or his legal representative.